Full-Text Search:
Home|Journal Papers|About CNKI|User Service|FAQ|Contact Us|中文
《Hereditas(Beijing)》 2005-01
Add to Favorite Get Latest Update

Use of Fetal Specific Antibody——HbF to Detect Fetal Erythroblasts for Non-invasive Prenatal Diagnosis of DMD

LIU Li-Ying~1,JIN Chun-Lian~1,LIN Chang-Kun~1,WU Ying-Yu~2,SUN Kai-Lai~1 (1.Department of Medical Genetics,China Medical University,Shenyang 110001,China;2.Affiliated 2nd hospital,China Medical University,Shenyang 110001,China)  
Maternal blood was obtained at 8~26 weeks of gestation.After discontinuous density gradient centrifugation with Percoll,HbF antibody was used to identify fetal NRBC.The precise differentiation between fetal and maternal NRBC is based on the constitutional difference between fetal and adult hemoglobin (Hb).Fetal cells appear yellow cytoplasmic staining,while adult cells colorless. NRBCs were collected by micromanipulation and whole genome amplification was performed. DMD was prenatally diagnosed by using the combination of sex determination,multiplex PCR and linkage analysis of several STR sites of dystrophin. NRBCs stained with HbF were found in all of 20 maternal blood samples with gestations, and seven fetuses with risk of DMD were diagnosed. We concluded that HbF antibody could identify fetal NRBC efficaciously,and this is a kind of more prospective application method.
【Fund】: "十五"国家科技攻关课题(2004BA720A04)~~
【CateGory Index】: R714.5
Download(CAJ format) Download(PDF format)
CAJViewer7.0 supports all the CNKI file formats; AdobeReader only supports the PDF format.
©2006 Tsinghua Tongfang Knowledge Network Technology Co., Ltd.(Beijing)(TTKN) All rights reserved